Fig. 2From: Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significanceSurvival curves of patients with positive and negative UGP2 expression in pancreatic ductal carcinoma (a) and positive and negative CFL1 expression in pancreatic ductal carcinoma (b)Back to article page